Endothelin-receptor antagonists: current and future perspectives

This publication has 51 references indexed in Scilit:

• Endothelins and asthma
  Life Sciences, 1999
• Clinical Experience With Endothelin Antagonists
  American Journal of Hypertension, 1998
• Clinical significance of endothelin in cardiovascular disease
  Current Opinion in Cardiology, 1997
• The increase in human plasma immunoreactive endothelin but not big endothelin‐1 or its C‐terminal fragment induced by systemic administration of the endothelin antagonist TAK‐044
  British Journal of Pharmacology, 1996
• Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects
  Clinical Pharmacology & Therapeutics, 1996
• Design and discovery of nonpeptide endothelin antagonists
  Drug Discovery Today, 1996
• The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine
  Drugs, 1996
• Endothelin: a knockout in London
  Trends in Pharmacological Sciences, 1995
• Contribution of endogenous generation of endothelin-1 to basal vascular tone
  The Lancet, 1994
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells
  Nature, 1988